COPG expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 2.097000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
2.051600E-01
Normal-vs-Stage2
2.001200E-01
Normal-vs-Stage3
7.908600E-01
Normal-vs-Stage4
1.668240E-01
Stage1-vs-Stage2
8.245800E-01
Stage1-vs-Stage3
3.712200E-01
Stage1-vs-Stage4
6.803600E-01
Stage2-vs-Stage3
3.077000E-01
Stage2-vs-Stage4
5.087200E-01
Stage3-vs-Stage4
2.994400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
2.359600E-01
Normal-vs-AfricanAmerican
1.929240E-01
Normal-vs-Asian
1.860780E-01
Caucasian-vs-AfricanAmerican
6.638800E-01
Caucasian-vs-Asian
6.417000E-01
AfricanAmerican-vs-Asian
9.399200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
2.116800E-01
Normal-vs-Female
2.223000E-01
Male-vs-Female
7.393600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
6.365400E-01
Normal-vs-Age(41-60Yrs)
8.676500E-02
Normal-vs-Age(61-80Yrs)
2.966400E-01
Normal-vs-Age(81-100Yrs)
2.480200E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
2.447000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
5.594600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
4.522600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.835840E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
6.985600E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
7.303800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
4.165800E-01
Normal-vs-Daily Drinker
4.674400E-01
Normal-vs-Weekly Drinker
1.790020E-01
Normal-vs-Occasional Drinker
1.307790E-01
Normal-vs-Social Drinker
1.082220E-01
Non Drinker-vs-Daily Drinker
7.089400E-01
Non Drinker-vs-Weekly Drinker
3.799000E-01
Non Drinker-vs-Occasional Drinker
3.856200E-02
Non Drinker-vs-Social Drinker
1.016650E-01
Daily Drinker-vs-Weekly Drinker
2.117200E-01
Daily Drinker-vs-Occasional Drinker
2.174500E-02
Daily Drinker-vs-Social Drinker
4.697600E-02
Weekly Drinker-vs-Occasional Drinker
2.841800E-01
Weekly Drinker-vs-Social Drinker
4.716800E-01
Occasional Drinker-vs-Social Drinker
6.526000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
3.974800E-01
Normal-vs-Grade 2
6.089000E-01
Normal-vs-Grade 3
6.013800E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
3.532800E-01
Grade 1-vs-Grade 3
3.196600E-01
Grade 1-vs-Grade 4
3.974800E-01
Grade 2-vs-Grade 3
8.469000E-01
Grade 2-vs-Grade 4
6.089000E-01
Grade 3-vs-Grade 4
6.013800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
4.291800E-01
Normal-vs-NonDiabetic
1.746220E-01
Diabetic-vs-NonDiabetic
7.602300E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
7.442400E-02
Normal-vs-NoPancreatitis
2.436000E-01
Pancreatitis-vs-NoPancreatitis
5.184800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
1.680360E-01
Normal-vs-N1
2.219000E-01
N0-vs-N1
7.770800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
6.367900E-02
Normal-vs-TP53-NonMutant
3.116400E-01
TP53-Mutant-vs-TP53-NonMutant
1.489630E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
